Credit Industriel ET Commercial bought a new position in shares of Masimo Corporation (NASDAQ:MASI – Free Report) during the 1st quarter, HoldingsChannel.com reports. The fund bought 23,050 shares of the medical equipment provider’s stock, valued at approximately $4,100,000.
Several other hedge funds also recently bought and sold shares of MASI. Global Retirement Partners LLC bought a new stake in Masimo during the 4th quarter worth approximately $27,000. Aster Capital Management DIFC Ltd purchased a new position in shares of Masimo during the 4th quarter valued at $28,000. Los Angeles Capital Management LLC bought a new position in shares of Masimo in the fourth quarter worth $31,000. Rothschild Investment LLC raised its position in shares of Masimo by 12,950.0% during the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 259 shares in the last quarter. Finally, Torren Management LLC bought a new stake in shares of Masimo during the 4th quarter worth $35,000. Hedge funds and other institutional investors own 85.96% of the company’s stock.
Analyst Ratings Changes
A number of analysts recently commented on MASI shares. Weiss Ratings raised Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Raymond James Financial cut Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday, March 27th. Finally, Wells Fargo & Company raised shares of Masimo to a “hold” rating in a research report on Wednesday, March 18th. Nine equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $180.40.
Masimo Price Performance
MASI stock opened at $179.95 on Tuesday. Masimo Corporation has a twelve month low of $125.94 and a twelve month high of $179.99. The company has a quick ratio of 1.45, a current ratio of 2.68 and a debt-to-equity ratio of 0.56. The stock has a market cap of $9.42 billion, a P/E ratio of -17.07, a PEG ratio of 1.82 and a beta of 1.11. The business’s 50-day moving average price is $179.17 and its 200-day moving average price is $165.04.
Masimo Company Profile
Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.
In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.
Recommended Stories
- Five stocks we like better than Masimo
- Big Beautiful Boycott: Can It Really Hurt Coca-Cola, Amazon, and Kraft Heinz Stocks?
- 3 Stocks With Solid Yields and Sustainabale Payouts Boost Dividends Once Again
- 2 Short Squeezes for Summer Speculation: What the Bears Are Getting Wrong
- How TeraWulf’s Anthropic Deal Booted Up a $19B AI Empire
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI – Free Report).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.
